Colecchia, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.417
AS - Asia 11.771
EU - Europa 7.842
SA - Sud America 2.914
Continente sconosciuto - Info sul continente non disponibili 329
AF - Africa 293
OC - Oceania 101
Totale 40.667
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.798
SG - Singapore 3.014
CN - Cina 2.888
SE - Svezia 2.305
BR - Brasile 2.291
HK - Hong Kong 2.014
IT - Italia 1.757
VN - Vietnam 1.528
GB - Regno Unito 960
FI - Finlandia 857
BD - Bangladesh 601
KR - Corea 548
RU - Federazione Russa 422
DE - Germania 315
CA - Canada 278
AR - Argentina 243
PL - Polonia 241
ID - Indonesia 226
BG - Bulgaria 208
FR - Francia 179
IN - India 179
JP - Giappone 140
EC - Ecuador 138
MX - Messico 123
NL - Olanda 114
AU - Australia 89
TR - Turchia 85
IQ - Iraq 73
ZA - Sudafrica 69
UA - Ucraina 67
PK - Pakistan 66
CO - Colombia 62
IE - Irlanda 62
CL - Cile 54
ES - Italia 54
AT - Austria 49
EG - Egitto 47
JM - Giamaica 47
LT - Lituania 45
AE - Emirati Arabi Uniti 44
PY - Paraguay 42
MA - Marocco 40
RO - Romania 40
UZ - Uzbekistan 39
PH - Filippine 38
VE - Venezuela 34
CR - Costa Rica 32
TH - Thailandia 31
IR - Iran 30
TN - Tunisia 30
KE - Kenya 25
MY - Malesia 25
BE - Belgio 23
PE - Perù 22
CZ - Repubblica Ceca 20
AZ - Azerbaigian 19
NP - Nepal 19
UY - Uruguay 19
HN - Honduras 18
NI - Nicaragua 18
GT - Guatemala 17
JO - Giordania 17
SA - Arabia Saudita 17
DZ - Algeria 16
TT - Trinidad e Tobago 16
CH - Svizzera 14
KZ - Kazakistan 14
PR - Porto Rico 14
SC - Seychelles 14
TW - Taiwan 14
BH - Bahrain 13
PT - Portogallo 13
MK - Macedonia 12
LB - Libano 11
PA - Panama 11
AL - Albania 10
DO - Repubblica Dominicana 10
GR - Grecia 10
IL - Israele 10
SV - El Salvador 10
BO - Bolivia 9
EE - Estonia 9
KG - Kirghizistan 9
NZ - Nuova Zelanda 9
BB - Barbados 8
DK - Danimarca 8
NG - Nigeria 8
ET - Etiopia 7
GH - Ghana 7
OM - Oman 7
PS - Palestinian Territory 7
QA - Qatar 7
CW - ???statistics.table.value.countryCode.CW??? 6
EU - Europa 6
KH - Cambogia 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
BS - Bahamas 5
HU - Ungheria 5
KW - Kuwait 5
Totale 40.247
Salva come PNG Salva come JPEG
Città #
Ashburn 2.127
Santa Clara 2.098
Hong Kong 1.979
Stockholm 1.792
Singapore 1.634
San Jose 1.271
Helsinki 817
Hefei 773
Council Bluffs 726
Fairfield 645
London 625
Ho Chi Minh City 520
Nyköping 472
Sunnyvale 457
Seoul 453
Beijing 444
Los Angeles 405
The Dalles 390
Hanoi 360
Chandler 331
New York 319
Boardman 284
São Paulo 281
Milan 267
Wilmington 266
Houston 259
Princeton 244
Buffalo 234
Woodbridge 234
San Diego 233
Warsaw 226
Sofia 205
Cambridge 203
Chicago 196
Shanghai 186
Seattle 170
Dallas 131
Rome 119
Jakarta 116
Modena 101
Bologna 99
Moscow 91
North Bergen 91
Da Nang 82
Orem 79
Phoenix 77
Porto Alegre 73
Port Wentworth 72
Rio de Janeiro 72
Melbourne 71
Salt Lake City 71
Tokyo 71
Nuremberg 68
Redondo Beach 67
Haiphong 66
Atlanta 64
Lauterbourg 58
Washington 58
Southend 57
Ann Arbor 56
Piscataway 56
Bupyeong-gu 53
Frankfurt am Main 52
Winter Springs 51
Belo Horizonte 50
Dublin 50
Saint Augustine 47
Elwood 46
Jacksonville 46
Quito 46
Jersey City 44
Kent 44
Toronto 44
San Francisco 43
Amsterdam 42
Elk Grove Village 42
Guangzhou 42
Montreal 42
Munich 42
Naples 42
Guayaquil 41
Brooklyn 39
Curitiba 39
Denver 39
Biên Hòa 38
Bremen 37
Columbus 36
Vancouver 36
Charlotte 34
Chennai 34
Florence 34
Johannesburg 34
Miano 34
Tampa 34
Tashkent 34
Reggio Emilia 33
Hải Dương 32
Dhaka 31
Palermo 31
Secaucus 30
Totale 25.660
Salva come PNG Salva come JPEG
Nome #
"Are the Expanded Baveno VI Criteria really safe to screen compensated cirrhotic patients for high-risk varices?" 1.984
Unlocking the Power of Late-Evening Snacks: Practical Ready-to-Prescribe Chart Menu for Patients with Cirrhosis 463
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma 463
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study 401
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 368
Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT 359
Gut Microbiota and Celiac Disease. 349
Creatine Supplementation to Improve Sarcopenia in Chronic Liver Disease: Facts and Perspectives 333
Diagnostic accuracy of FibroScan-AST (FAST) score for the non-invasive identification of patients with fibrotic non-alcoholic steatohepatitis: A systematic review and meta-analysis 316
Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study. 315
Role of Vitamin D in Liver Disease and Complications of Advanced Chronic Liver Disease 310
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma 305
Adverse Food Reaction and Functional Gastrointestinal Disorders: Role of the Dietetic Approach 304
A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices 302
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 292
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice 289
Non-invasive methods can predict oesophageal varices in patients with biliary atresia after a Kasai procedure. 271
Transjugular Intrahepatic Portosystemic Shunt: Devices Evolution, Technical Tips and Future Perspectives 268
A Combined Baveno VII and Spleen Stiffness Algorithm to Improve the Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease 267
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project) 267
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 259
A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease 259
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 258
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation 257
Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study 249
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 243
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma 238
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 236
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma 235
The evolutionary scenario of hepatocellular carcinoma in Italy: an update 235
Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients: a review of the literature 233
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease 231
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model 230
Pneumocystis jirovecii pneumonia in patients with decompensated cirrhosis: a case series 230
Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis 222
Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients 221
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 220
Hepatic venous pressure gradient in the preoperative assessment of patients with resectable hepatocellular carcinoma 220
Post COVID-19 irritable bowel syndrome 217
The safety of Sonovue® in abdominal applications: Retrospective analysis of 23188 investigations 217
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 216
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma 214
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study 212
Growth and nutritional evaluation in children with chronic liver disease (CLD) before and after liver transplantation 209
Hepatic steatosis in obese patients: clinical aspects and prognostic significance 207
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference 207
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 206
Gut microbiota and metabolic syndrome 204
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 203
Gut microbiota signatures and clinical manifestations in celiac disease children at onset: a pilot study 203
Review article:the diagnosis of non-alcoholic fatty liver disease-availability and accuracy of non-invasive methods 202
EFFICACY OF CERTOLIZUMAB PEGOL FOR DISEASE CONTROL OF PATIENTS AFFECTED BY ENTEROPATHIC SPONDYLARTHRITIS FOLLOWED BY THE JOINT GASTRO-RHEUMATOLOGICAL CLINIC 199
Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension 199
Transient Elastography (FibroScan) Is Not Correlated With Liver Fibrosis but With Cholestasis in Patients With Long-Term Home Parenteral Nutrition 198
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 198
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 197
Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder 193
Gut microbiota and its pathophysiology in disease paradigms 189
Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly 187
Porto-sinusoidal vascular disorder in surgical candidates for liver metastases: Prevalence, noninvasive diagnosis, and burden on surgical outcomes. 186
From Listing to Recovery: A Review of Nutritional Status Assessment and Management in Liver Transplant Patients 186
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 186
A new point-of-care portable immunosensor for non-invasive assessment of oro-ileal transit time by oral fluid tauroursodeoxycholate measurement after its oral load 184
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 183
Predictive factors for hepatocellular carcinoma recurrence after curative treatments 181
Antibiotic prophylaxis in patients with cirrhosis: Current evidence for clinical practice 180
The management of endoscopic retrograde cholangiopancreatography related infections risk: results of an italian survey at regional level 179
Gallbladder motility and gallstone formation in obese patients following very low calorie diets. Use it (fat) to lose it (well) 178
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease 177
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 177
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 175
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients 175
Clinical manifestations of gallstone disease: evidence from the multicenter Italian study on cholelithiasis (MICOL) 171
Relationship between hepatic hemodynamics assessed by Doppler ultrasound and liver stiffness 170
Clinical presentation of celiac disease and diagnosis accuracy in a single-center european pediatric cohort over 10 years 168
A spleen stiffness measurement-based model for recognition of high risk varices: Baveno VI criteria and beyond 167
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 166
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 165
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients 164
Liver fibrosis by FibroScan(®) independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes 163
Suppressing, stimulating and/or inhibiting: The evolving management of HCC patient after liver transplantation 162
Dysbiosis in Celiac disease patients with persistent symptoms on gluten-free diet: a condition similar to that present in irritable bowel syndrome patients? 162
The interplay between sarcopenia and portal hypertension predicts ascites and mortality in cirrhosis 161
Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation 161
Pre-transplant psoas muscle density as a ready-to-use and low-cost predictor of patient survival after liver transplant 161
Benign hepatic nodular lesions after treatment for childhood cancer 159
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis 158
Value of Transient Elastography Measured With Fibroscan in Predicting the Outcome of Hepatic Resection for Hepatocellular Carcinoma 156
Validation of a standardized CT protocol for the evaluation of varices and porto-systemic shunts in cirrhotic patients 153
Association between lower plasma adiponectin levels and higher liver stiffness in type 2 diabetic individuals with nonalcoholic fatty liver disease: an observational cross-sectional study 150
Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon 150
Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations 150
The role of liver and spleen elastography in advanced chronic liver disease 149
Corrigendum to “Idiopathic pulmonary fibrosis and intestinal disorders: An observational study” [Ann Diagn Pathol 62 (2023) 152072] (Annals of Diagnostic Pathology (2023) 62, (S1092913422001745), (10.1016/j.anndiagpath.2022.152072)) 147
Probiotics, Prebiotics and Other Dietary Supplements for Gut Microbiota Modulation in Celiac Disease Patients 147
A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study 145
Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease 144
Concomitant Autoimmune Liver Disease and Hepatic Actinomycosis: A Diagnostic Challenge—Brief Report and Review of the Literature 143
Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease 143
The role of Spleen Stiffness measurement as predictor of HCC recurrence after curative resection in cirrhotic patients 141
Totale 23.502
Salva come PNG Salva come JPEG
Categoria #
all - tutte 206.479
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 206.479
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.492 0 0 0 8 34 29 743 185 338 48 754 353
2022/20231.813 307 184 151 85 162 208 46 249 211 30 87 93
2023/20242.351 30 91 133 139 469 157 129 220 364 140 130 349
2024/20257.601 141 33 55 540 1.415 1.030 683 358 1.029 447 611 1.259
2025/202619.034 956 761 1.916 2.725 1.323 1.085 2.194 1.034 3.258 1.434 1.338 1.010
2026/20276.528 960 1.812 1.818 1.938 0 0 0 0 0 0 0 0
Totale 40.667